Fatma Ben Abid - Infectious Diseases

Author Information

Fatma Ben Abid is a researcher affiliated with the Department of Medicine, Division of Infectious Diseases at Hamad Medical Corporation in Doha, Qatar. Her work primarily focuses on infectious diseases, contributing to both clinical and molecular aspects of the field. Her research has been pivotal in understanding the dynamics of infectious diseases within the Qatari demographic.

Research Contributions

Fatma Ben Abid has made substantial contributions to the field of infectious diseases, with a special focus on the epidemiology and molecular characteristics of pathogens. Her research encompasses a variety of studies, including the molecular characterization of Neisseria meningitidis and carbapenem-resistant Enterobacterales, as well as investigations into COVID-19, such as the clinical characteristics and risk factors associated with COVID-19-associated candidemia. Her work also extends to the study of other infectious agents, such as Salmonella and Rhodotorula mucilaginosa, highlighting her diverse expertise in the field.

Aliases

Fatma Ben Abid is also known by several aliases including F Abid, Fatma Abid, and Fatma B Abid. These variations are often used interchangeably in her publications and academic circles.

Publication and Citation Metrics

Metric	Value
Total Papers	24
Citation Count	120
h-index	6

Publications:

Characteristics and comparisons of acute stroke in “recovered" to “active COVID-19 and “pre-pandemic” in Qatar database

DOI: 10.1007/s11239-021-02581-6

Year: 2022

Salmonella-induced pulmonary and pericardial abscesses in a patient presenting with subacute cough

DOI: 10.1016/j.idcr.2022.e01430

Year: 2022

Central line‐associated Rhodotorula mucilaginosa fungemia in an immunocompetent host: Case report and review of the literature

DOI: 10.1002/ccr3.3969

Year: 2021

Draft Genome Sequence of Rhodotorula mucilaginosa from an Adult Patient in Qatar

DOI: 10.1128/MRA.00725-21

Year: 2021

Molecular characteristics of Neisseria meningitidis in Qatar

DOI: 10.1038/s41598-021-84262-1

Year: 2021

Molecular characterization of clinical carbapenem-resistant Enterobacterales from Qatar

DOI: 10.1007/s10096-021-04185-7

Year: 2021

1247. Molecular Epidemiology of Multi-drug Resistant Klebsiella pneumoniae and K. quasipneumoniae in Qatar

DOI: 10.1093/ofid/ofab466.1439

Year: 2021

Clinical Characteristics and Risk Factors for COVID-19-associated Candidemia.

DOI: 10.1093/mmy/myab056

Year: 2021

508. Title Favipiravir for the Treatment of Coronavirus Disease 2019; A Propensity Score Matched Cohort Study

DOI: 10.1093/ofid/ofab466.707

Year: 2021

The first consecutive 5000 patients with Coronavirus Disease 2019 from Qatar; a nation-wide cohort study

DOI: 10.1186/s12879-020-05511-8

Year: 2020

Can Antivirals Be Used for Prevention?

What Are the Symptoms of These Diseases?

What are the common viruses treated by DAAs?

What Are the Implications for Public Health?

Can Dexamethasone be used in all patients with infectious diseases?

How Can HSV Be Prevented?

How Can Individuals Protect Themselves?

Are There Any Limitations to Wearing Masks?

What are the Symptoms of Ebola?

How are Chest CT Scans Performed?

Partnered Content Networks

Relevant Topics